mGluR5 as a Potential Orchestrator of Astrocyte Interactions in Neurological Disorders
Neural Plasticity · 2025
DOI: 10.1155/np/7259018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neural Plasticity, 2025. Verfasst von Jeongseop Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emotion, Cognition and Behavior Research Group, Korea Brain Research Institute, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Receptor, Metabotropic Glutamate 5, Astrocytes, Nervous System Diseases, Cell Communication. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soonchunhyang University, Global Convergence Research Support.
Abstract (Originalsprache)
Astrocytes and metabotropic glutamate receptor 5 (mGluR5) have emerged as pivotal regulators of synaptic homeostasis and neural communication within the central nervous system (CNS). Although mGluR5 has long been considered neuron‐specific, its functional expression in astrocytes is now recognized as essential for calcium (Ca 2+ ) signaling, gliotransmission, and the modulation of synaptic plasticity. Dysregulation of astrocytic mGluR5 is increasingly implicated in the pathophysiology of neurodegenerative and psychiatric disorders including Alzheimer’s disease (AD), Parkinson’s disease (PD), depression, anxiety, and schizophrenia (SCZ) by promoting neuroinflammation, excitotoxicity, and synaptic dysfunction. In this review, we explore the emerging role of astrocytic mGluR5 in mediating astrocyte‐neuron communication and its maladaptive regulation in disease contexts. We also assess the therapeutic potential of targeting astrocytic mGluR5, highlighting advances in pharmacological modulators, gene therapy, and RNA‐based strategies aimed at restoring homeostatic function. Despite recent progress, critical knowledge gaps remain, particularly regarding the regional specificity of astrocytic mGluR5 effects, its crosstalk with other signaling pathways, and its contribution to chronic neuroinflammation. Addressing these challenges may unlock innovative astrocyte‐targeted therapies to restore synaptic integrity and protect against neurodegeneration in CNS disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emotion, Cognition and Behavior Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
- Department of Pharmacology, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.
- Department of Pharmacology, College of Medicine, Soonchunhyang University, Cheonan-si, Republic of Korea.
- Department of Brain and Cognitive Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Republic of Korea.
ORCID-Profile: Ja Wook Koo, Shinwoo Kang
Förderung
- Soonchunhyang University
- Global Convergence Research Support
Zitieren
APA
Kim, J., Lee, J., Song, H., Koo, J. W., & Kang, S. (2025). mGluR5 as a Potential Orchestrator of Astrocyte Interactions in Neurological Disorders. Neural Plasticity. https://doi.org/10.1155/np/7259018
Vancouver
Kim J, Lee J, Song H, Koo JW, Kang S. mGluR5 as a Potential Orchestrator of Astrocyte Interactions in Neurological Disorders. Neural Plasticity. 2025. doi:10.1155/np/7259018
BibTeX
@article{Kim2025,
author = {Kim, Jeongseop and Lee, Jiyong and Song, Hyein and Koo, Ja Wook and Kang, Shinwoo},
title = {mGluR5 as a Potential Orchestrator of Astrocyte Interactions in Neurological Disorders},
journal = {Neural Plasticity},
year = {2025},
doi = {10.1155/np/7259018}
}
EUVIMED